283 related articles for article (PubMed ID: 37175680)
1. Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019.
Wada H; Shiraki K; Shimpo H; Shimaoka M; Iba T; Suzuki-Inoue K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175680
[TBL] [Abstract][Full Text] [Related]
2. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Ahmed S; Zimba O; Gasparyan AY
Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-related thrombotic complications experience before and during delta wave.
Manzur-Pineda K; O'Neil CF; Bornak A; Lalama MJ; Shao T; Kang N; Kennel-Pierre S; Tabbara M; Velazquez OC; Rey J
J Vasc Surg; 2022 Nov; 76(5):1374-1382.e1. PubMed ID: 35700857
[TBL] [Abstract][Full Text] [Related]
4. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
5. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
[TBL] [Abstract][Full Text] [Related]
6. The Impact of COVID-19 Disease on Platelets and Coagulation.
Wool GD; Miller JL
Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
[TBL] [Abstract][Full Text] [Related]
7. Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis-Induced Neutropenia.
Di Micco P; Imparato M; Lubrano G; Iannuzzo D; Fontanella L; Improta L; Poggiano MR; Salzano C; Rodolico A; Fontanella A
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33498929
[TBL] [Abstract][Full Text] [Related]
8. Venous Thrombosis and SARS-CoV-2.
Zdanyte M; Rath D; Gawaz M; Geisler T
Hamostaseologie; 2022 Aug; 42(4):240-247. PubMed ID: 34879422
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Al-Samkari H; Karp Leaf RS; Dzik WH; Carlson JCT; Fogerty AE; Waheed A; Goodarzi K; Bendapudi PK; Bornikova L; Gupta S; Leaf DE; Kuter DJ; Rosovsky RP
Blood; 2020 Jul; 136(4):489-500. PubMed ID: 32492712
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H; Ogawa H
Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
[TBL] [Abstract][Full Text] [Related]
11. Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count.
Ishikura H; Irie Y; Kawamura M; Hoshino K; Nakamura Y; Mizunuma M; Maruyama J; Nakashio M; Suzuki-Inoue K; Kitamura T
Platelets; 2022 Aug; 33(6):935-944. PubMed ID: 35073814
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 versus HIT hypercoagulability.
Warkentin TE; Kaatz S
Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features and Management of COVID-19-Associated Hypercoagulability.
Massaro G; Lecis D; Martuscelli E; Chiricolo G; Sangiorgi GM
Card Electrophysiol Clin; 2022 Mar; 14(1):41-52. PubMed ID: 35221084
[TBL] [Abstract][Full Text] [Related]
14. Congenital Bleeding Disorders and COVID-19 - An Emphasis on the Role of Thrombosis as One of the Main Causes of Morbidity and Mortality in COVID-19.
Dorgalaleh A; Narouei F; Asadi M; Khamsi HM; Gholami MS
Cardiovasc Hematol Disord Drug Targets; 2022; 22(2):83-86. PubMed ID: 35702769
[TBL] [Abstract][Full Text] [Related]
15. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.
Gorog DA; Storey RF; Gurbel PA; Tantry US; Berger JS; Chan MY; Duerschmied D; Smyth SS; Parker WAE; Ajjan RA; Vilahur G; Badimon L; Berg JMT; Cate HT; Peyvandi F; Wang TT; Becker RC
Nat Rev Cardiol; 2022 Jul; 19(7):475-495. PubMed ID: 35027697
[TBL] [Abstract][Full Text] [Related]
16. A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study.
Shazley O; Alshazley M
Cureus; 2021 Jul; 13(7):e16383. PubMed ID: 34408937
[TBL] [Abstract][Full Text] [Related]
17. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
Levi M; Iba T
Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 and coagulation disorders in different organs.
Vinayagam S; Sattu K
Life Sci; 2020 Nov; 260():118431. PubMed ID: 32946915
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 coagulopathy - what should we treat?
Chowdary P
Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
